Presenting
Learning Objectives
By the end of the review, attendees will be better equipped to:
- Identify which patients with hematologic malignancies would benefit from specific targeted therapies.
- Recognize a myriad of presentations of patients with hematologic malignancies.
- Identify higher-risk patients with hematologic malignancies and appropriate therapies for these patients.
- Identify the best approach to patients requiring more aggressive treatment.
- Identify complications of hematologic malignancies and their appropriate management in an outpatient setting.
- Review the diagnosis and treatment of benign hematologic diseases such as sickle cell anemia, coagulopathies, and autoimmune hemolytic anemias.
Continuing Education Credit
CONTINUING MEDICAL EDUCATION
The University of Colorado School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Colorado School of Medicine designates this live activity for a maximum of 3.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CONTINUING NURSING EDUCATION
CNE credit is 3.5 hours.
This activity has been supported
by an educational grant from Daiichi Sankyo
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 3.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
To earn board credit, the attendee must participate in the CME activity including the evaluation component. By participating in this event and requesting board credit, I understand that my learner completion data will be shared with the ACCME and the applicable certifying board(s).
PARTS I & II
Yes!
Parts 1 & 2
